11mon
Verywell Health on MSNCommon Pericarditis Symptoms (and How Pericarditis Is Diagnosed)Pericarditis is a relatively common disease, accounting for around 5% of all causes of chest pain seen in the emergency room.
13d
First for Women on MSNCarly Pearce on Her Pericarditis Symptoms: ‘It Felt Like Breathing Through a Straw'Carly Pearce has made waves in country music with her singing and songwriting, and even earned a Grammy in 2023 for her song ...
5d
HealthDay on MSNPericarditis Recurrence Occurs in About 20% of Patients With LupusFor patients with systemic lupus erythematosus (SLE) and pericarditis, recurrence of pericarditis occurs in more than 20% of patients and associated factors include younger age, prednisone treatment, ...
Pericarditis, or inflammation of the pericardium, has typical ECG findings. These findings occur in progressive stages, all of which are seen in about 50% of cases of pericarditis. Stage I (acute ...
But suddenly Braxton found herself being rushed to the hospital. There,doctors told her she had pericarditis, a serious heart condition. Often caused by a virus, pericarditis is an inflammation of ...
Kiniksa plans to initiate a Phase 2/3 clinical trial of KPL-387 in recurrent pericarditis in mid-2025 – – KPL-387 Phase 1 single ascending dose data support potential monthly dosing ...
The subsequent absorption of the effusion with organization may lead to scarring and calcification, and a possible final evolution with constrictive pericarditis. A response to a trial of anti ...
News Medical on MSN16d
Steroids Should Be Used Cautiously, New Study SuggestsA new study of more than 2,900 patients provides evidence that it’s likely best to use as little corticosteroid medicine as possible when treating people who have lupus pericarditis, a common heart ...
11d
Zacks.com on MSNKiniksa Pharmaceuticals (KNSA) Soars 5.8%: Is Further Upside Left in the Stock?Kiniksa Pharmaceuticals (KNSA) witnessed a jump in share price last session on above-average trading volume. The latest trend ...
Kiniksa shifts focus to cardiovascular indications, halts abiprubart in Sjögren's, ends its AstraZeneca deal, and advances ...
“Through the successful development and commercialization of ARCALYST, Kiniksa has helped thousands of patients suffering from recurrent pericarditis. Since the launch in 2021, we have generated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results